Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?
Wang, Shuai
Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? [electronic resource] - Oncotarget Jul 2015 - 18206-23 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1949-2553
10.18632/oncotarget.4524 doi
Angiogenesis Inhibitors--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Chi-Square Distribution
Disease Progression
Disease-Free Survival
Humans
Lung Neoplasms--drug therapy
Molecular Targeted Therapy
Neoplasm Staging
Odds Ratio
Protein Kinase Inhibitors--adverse effects
Randomized Controlled Trials as Topic
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Risk Factors
Signal Transduction--drug effects
Survival Analysis
Time Factors
Treatment Outcome
Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? [electronic resource] - Oncotarget Jul 2015 - 18206-23 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1949-2553
10.18632/oncotarget.4524 doi
Angiogenesis Inhibitors--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Chi-Square Distribution
Disease Progression
Disease-Free Survival
Humans
Lung Neoplasms--drug therapy
Molecular Targeted Therapy
Neoplasm Staging
Odds Ratio
Protein Kinase Inhibitors--adverse effects
Randomized Controlled Trials as Topic
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Risk Factors
Signal Transduction--drug effects
Survival Analysis
Time Factors
Treatment Outcome